the therapeutic efficacy of amikacin was evaluated in patients with serious hospital-acquired infections caused by gram-negative bacilli susceptible to amikacin , but usually resistant to kanamycin , gentamicin , and tobramycin .
C0002499
amikacin
C0022487
kanamycin